SOFIE
Quick facts
Phase 3 pipeline
- [18F]FAPI-74 PET/CT · Oncology
This drug is a PET imaging agent that targets the fibroblast activation protein (FAP) for the visualization of tumors.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: